Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Cisapride Compounded is dosed at 0.1–0.5 mg/kg PO q8h in dogs, per Whitehead K, Cortes Y, Eirmann L. Gastrointestinal dysmotility disorders in critically ill dogs and cats. J Vet Emerg Crit Car. 2016;26(2):234-253. doi:10.1111/vec.12449 — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.297 (2026-08-01).. Cisapride Compounded is used in dogs for Gastric motility disorders. Routes documented in dogs: PO. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Cisapride Compounded in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Compounded Cisapride
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| PO | 0.1–0.5 mg/kg | q8h | Long-term for chronic motility disorders | Gastric motility disorders | Moderate | Whitehead K, Cortes Y, Eirmann L. Gastrointestinal dysmotility disorders in critically ill dogs and cats. J Vet Emerg Crit Car. 2016;26(2):234-253. doi:10.1111/vec.12449 — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.297 (2026-08-01). |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
5-HT4 receptor agonist that enhances acetylcholine release in myenteric plexus, increasing GI motility throughout the GI tract. Also weak 5-HT3 antagonist.
Removed from human market (cardiac arrhythmias) but available compounded for veterinary use. QT prolongation risk. Do not combine with azole antifungals or erythromycin.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Cisapride Compounded dose range in dogs, with cited source references: PO 0.1–0.5 mg/kg q8h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Cisapride Compounded in dogs: PO.
Cited course lengths for Cisapride Compounded in dogs include: Long-term for chronic motility disorders. Duration depends on the indication — match it to the specific dose rule in the table above.
Cisapride Compounded is indicated in dogs for: Gastric motility disorders.
These are general warnings for Cisapride Compounded across species; consult the dog dosing table above for species-specific guidance. Removed from human market (cardiac arrhythmias) but available compounded for veterinary use. QT prolongation risk. Do not combine with azole antifungals or erythromycin.
Why a species-specific page? Cisapride Compounded pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.